David Beversdorf, MD
Speaker
Dr. Beversdorf graduated from Indiana University and completed Neurology residency at Dartmouth. After his fellowship in Behavioral Neurology at University of Florida, he joined the Ohio State University faculty. He has published on memory disorders, autism, cognitive neuroscience, fMRI, neurpsychopharmacology and drug addiction. He joined the University of Missouri (Radiology, Neurology, Psychology and the Thompson Center) to focus on autism, with particular interest in pharmacofMRI as a potential treatment marker, and gene/stress interactions in autism.
Dr. Beversdorf is currently involved in research on autism, dementia, cognitive effects of stress, the cognitive neuroscience of problem solving ability, functional neuroimaging, and pharmacological modulation of cognition. His work has been published in journals such as Neurology, Journal of Neurology Neuroscience and Psychiatry, Proceedings of the National Academy of Sciences of the United State of America and Lancet. He is also actively involved in the Brain Imaging Center at the University of Missouri. His research has been funded by National Institute of Neurological Diseases and Stroke, National Institute On Drug Abuse, Department of Defense, the Stallone Fund and the National Alliance for Autism Research. He has joined the University of Missouri in the departments of Radiology, Neurology, Psychology and the Thompson Center to focus on the field of autism, with particular interest in pharmaco-functional neuroimaging as a potential treatment marker, and gene/stress interactions in the development of autism.
Webinars
February 9, 2026
Increased reaction to stress with GI symptoms
David Beversdorf, MD
One in 31 American children lives with autism spectrum disorder, according to the Centers for Disease Control and Prevention. Many…
February 9, 2026
Prenatal stress and neurodevelopment
David Beversdorf, MD
Dr. Beversdorf discusses prenatal stress and its implication in autism etiology. He provides a brief history of autism heredity, epigenetics,…
February 4, 2026
Propranolol and Autism
David Beversdorf, MD
An estimated 1 in 68 children in the United States has autism. The neurodevelopmental disorder, which impairs communication and social…